throbber

`
`Nos. 19-1434, 19-1452, 19-1458
`================================================================================================================
`
`In The
`Supreme Court of the United States
`--------------------------------- ♦ ---------------------------------
`
`UNITED STATES OF AMERICA,
`Petitioner,
`
`v.
`
`ARTHREX, INC., ET AL.,
`Respondents.
`
`--------------------------------- ♦ ---------------------------------
`On Writs Of Certiorari To The
`United States Court Of Appeals
`For The Federal Circuit
`--------------------------------- ♦ ---------------------------------
`BRIEF OF AMICI CURIAE THE COMPUTER &
`COMMUNICATIONS INDUSTRY ASSOCIATION
`AND U.S. MANUFACTURER’S ASSOCIATION FOR
`DEVELOPMENT AND ENTERPRISE IN SUPPORT
`OF UNITED STATES AND SMITH & NEPHEW
`--------------------------------- ♦ ---------------------------------
`
`JOSHUA LANDAU
` Counsel of Record
`COMPUTER & COMMUNICATIONS
` INDUSTRY ASSOCIATION
`25 Massachusetts Ave. NW
`Suite 300C
`Washington, DC 20001
`(202) 783-0070 x116
`jlandau@ccianet.org
`Counsel for Amici Curiae
`
`[Additional Captions On Inside Cover]
`
`================================================================================================================
`COCKLE LEGAL BRIEFS (800) 225-6964
`WWW.COCKLELEGALBRIEFS.COM
`
`
`
`

`

`
`
`--------------------------------- ♦ ---------------------------------
`
`SMITH & NEPHEW, INC., ET AL.,
`Petitioners,
`
`v.
`
`ARTHREX, INC., ET AL.
`
`--------------------------------- ♦ ---------------------------------
`
`ARTHREX, INC.,
`
`
`
`v.
`
`Petitioner,
`
`SMITH & NEPHEW, INC., ET AL.
`
`--------------------------------- ♦ ---------------------------------
`
`
`
`
`

`

`i
`
`TABLE OF CONTENTS
`
`4
`
`5
`
`Page
`TABLE OF AUTHORITIES .................................
`iii
`INTERESTS OF AMICI CURIAE .......................
`1
`SUMMARY OF ARGUMENT ..............................
`2
`ARGUMENT ........................................................
`4
`
`I. THE DIRECTOR ALONE HAS THE
`ABILITY TO FORMULATE POLICY .......
`A. The Director Formulates Policy Via
`Rulemaking; APJs Implement That
`Policy ...................................................
`B. The Director Formulates Policy Via
`Designation of Opinions as Precedential;
`APJs Are Bound to Follow That
`Precedent .............................................
` II. THE DIRECTOR HAS THE ABILITY TO
`EFFECTIVELY DIRECT AND CONTROL
`ADMINISTRATIVE PATENT JUDGES,
`RENDERING
`THEM
`INFERIOR
`OFFICERS .................................................
`A. The Director Bears Sole Authority to
`Set the Policies the APJs Must Follow,
`Directing Their Actions .......................
`B. The Director Controls Whether an
`APJ Will Hear Any Particular Case, or
`Even Whether the APJ Will Hear Any
`Cases at All ..........................................
`
`8
`
`6
`
`7
`
`8
`
`

`

`ii
`
`TABLE OF CONTENTS—Continued
`
`9
`
`Page
`1. The independent counsel in Morrison
`was sufficiently subject to control by
`the Attorney General .......................
`2. APJs are subject to analogous, but
`greater, control by the Director ...... 10
`3. If the independent counsel of Morri-
`son is an inferior officer, then APJs—
`subject to greater control and less in-
`sulated from removal—must also
`be ..................................................... 11
`C. The Director Can Unilaterally Determine
`to Rehear an APJ’s Decision, and Can
`Do So Accompanied by Hand-Picked
`Subordinates to Ensure the Desired
`Outcome ............................................... 12
` III. UNIFORM ADHERENCE BY ADMINI-
`STRATIVE PATENT JUDGES TO THE
`DIRECTOR’S EXTRASTATUTORY POLI-
`CIES SIGNALS THE DIRECTOR’S
`EFFECTIVE CONTROL ........................... 15
` IV. INTER PARTES REVIEW HAS SIGNI-
`FICANTLY IMPROVED THE FUNCTION
`OF THE PATENT SYSTEM AND
`CONGRESS WOULD NOT WISH TO
`DISTURB THAT IMPROVEMENT ........... 16
`CONCLUSION ..................................................... 18
`
`

`

`iii
`
`TABLE OF AUTHORITIES
`
`Page
`
`CASES
`Apple et al. v. Iancu, Case No. 5:20-CV-6128
`(N.D. Cal., filed Aug. 31, 2020) ................................ 15
`Arthrex, Inc. v. Smith & Nephew, Inc., 953 F.3d
`760 (Fed. Cir. 2020) ................................................. 12
`Ayotte v. Planned Parenthood of N. New
`England, 546 U.S. 320 (2006) ................................. 17
`Broad Institute v. Regents of the University of
`California, Interference No. 106,115 ...................... 18
`Cisco Systems, Inc. v. Ramot At Tel Aviv
`University, Ltd., IPR2020-00123, Paper No. 14
`(May 15, 2020) ......................................................... 15
`Cuozzo Speed Technologies, LLC v. Lee, 136
`S. Ct. 2131 (2016) .................................................... 14
`Edmond v. United States, 520 U.S. 651 (1997) .... 5, 7, 9
`Morrison v. Olson, 487 U.S. 654 (1988) ... 4, 9, 10, 11, 12
`Murphy v. NCAA, 138 S. Ct. 1461 (2018) ................... 18
`
`STATUTES
`5 U.S.C. § 7513 ............................................................ 11
`28 U.S.C. § 592 ............................................................ 10
`28 U.S.C. § 594 ............................................................ 10
`28 U.S.C. § 596 ............................................................ 10
`35 U.S.C. § 3 ............................................................ 8, 13
`35 U.S.C. § 3(a)(1) ......................................................... 7
`
`

`

`iv
`
`TABLE OF AUTHORITIES—Continued
`
`Page
`35 U.S.C. § 6 ...................................................... 9, 10, 13
`35 U.S.C. § 311 et seq. ................................................... 4
`35 U.S.C. § 312 ............................................................ 10
`35 U.S.C. § 314 ........................................................ 9, 10
`35 U.S.C. § 316 ...................................................... 4, 5, 8
`
`OTHER AUTHORITIES
`AIPLA, Report of the Economic Survey 2019
`(2019) ....................................................................... 16
`H.R. Rep. No. 112-98 (2011) ....................................... 17
`Landau, IPR and Alice Appear Responsible for
`Reduced Patent Litigation Costs, Patent
`Progress (Oct. 18, 2018) .......................................... 16
`Transcript of Argument in Oil States v. Greene’s
`Energy (Nov. 27, 2017) ............................................ 13
`Unified Patents, 2019 Patent Dispute Report—
`Year in Review (Jan. 1, 2020) .................................. 16
`USPTO Performance and Accountability Report,
`FY2020 (Nov. 2020) ................................................. 13
`USPTO, PTAB Standard Operating Procedure 1
`(Revision 15) ........................................................ 9, 10
`USPTO, PTAB Standard Operating Procedure 2
`(Revision 10) .............................................................. 6
`
`
`
`
`
`
`

`

`v
`
`TABLE OF AUTHORITIES—Continued
`
`Page
`
`REGULATIONS
`83 Fed. Reg. 39989 (Aug. 13, 2018) .............................. 5
`83 Fed. Reg. 51340 (Oct. 11, 2018) ............................... 5
`84 Fed. Reg. 33925 (July 16, 2019) ............................... 5
`84 Fed. Reg. 50 (Jan. 7, 2019) ....................................... 5
`84 Fed. Reg. 9497 (Mar. 15, 2019) ................................ 5
`
`

`

`1
`
`INTERESTS OF AMICI CURIAE1
`The Computer & Communications Industry Asso-
`
`ciation (CCIA) is an international, nonprofit associa-
`tion
`representing
`a
`broad
`cross-section
`of
`communications and technology firms. For nearly fifty
`years, CCIA has promoted open markets, open sys-
`tems, and open networks. CCIA members employ more
`than 1.6 million workers, invest more than $100 billion
`in research and development, and contribute trillions
`of dollars in productivity to the global economy.2 CCIA
`regularly files amicus briefs in this and other courts to
`promote balanced patent policies that reward, rather
`than stifle, innovation.
`
`U.S. Manufacturers’ Association for Development
`
`and Enterprise (US MADE) is a nonprofit association
`representing companies manufacturing diverse goods
`in the United States. US MADE members range from
`some of the largest U.S. manufacturers to the smallest
`father and son business. While US MADE members
`have collectively received hundreds of thousands of pa-
`tents to undergird their innovative enterprises, they
`have also been the targets of abusive patent litigation.
`Thus, US MADE was specifically created to preserve
`and strengthen efficient and cost-effective mechanisms
`
`
`1 Pursuant to Supreme Court Rule 37.3, all parties have
`
`given consent to the filing of this brief. Pursuant to Rule 37.6, no
`counsel for any party authored this brief in whole or part; no party
`or counsel made a monetary contribution intended to fund its
`preparation or submission; and no person other than amici made
`such a contribution.
`2 CCIA’s members are listed at http://www.ccianet.org/members.
`
`
`

`

`2
`
`to cancel improvidently granted patents that can be
`used to threaten U.S. manufacturing.3
`The inter partes review (IPR) proceeding, created
`
`to provide the United States Patent and Trademark
`Office (USPTO) with the ability to review the patenta-
`bility of patents after they were issued, has had a sig-
`nificant positive impact on the innovation ecosystem.
`Litigation costs and patent litigation frequency have
`come down from their peak, and the quality of patents
`asserted in litigation has increased.
`Amici’s members regularly file petitions for IPR.
`
`They rely on an effective and consistent IPR system as
`part of their innovative activities, in particular to man-
`age risk and cost from patent assertions by non-prac-
`ticing entities. The Arthrex decision threatens not just
`the efficient operation of the IPR system, but the ben-
`efits that IPR has brought to the patent ecosystem as
`a whole.
`
`--------------------------------- ♦ ---------------------------------
`
`SUMMARY OF ARGUMENT
`
`Administrative Patent Judges (APJs) of the Pa-
`
`tent Trial and Appeal Board (PTAB) unquestionably
`exercise significant authority on behalf of the United
`States. This renders them officers.
`
`However, the Director maintains the sole ability to
`
`formulate policy for the PTAB. APJs have no ability to
`
`3 US MADE’s members are listed at: https://us-made.org/
`
`members/.
`
`

`

`3
`
`formulate policy that binds the United States; to the
`extent any decision may become binding policy, that
`occurs only with the Director’s approval. This lack of
`policy-making authority is a signal that APJs are infe-
`rior officers, not principals.
`
`Further, the authority APJs exercise is fundamen-
`
`tally subordinated to the direction and authority of the
`Director of the USPTO. They are bound to abide by the
`policy directives he creates, exercise authority only
`with his permission, may have their exercise of author-
`ity in a case terminated by his sole decision, and their
`decisions are subject to re-hearing at his discretion.
`These tools of control and supervision are fundamen-
`tally the type of tools applied by a principal officer to
`direct an inferior officer.
`
`Finally, the Director has created policies that lie
`
`outside those authorized by the PTAB’s organic stat-
`ute. These policies have led to challenges under the
`Administrative Procedure Act. Despite this, there have
`been no instances in which a PTAB judge failed to ad-
`here to them. This uniform adherence to questionable
`policy guidance illustrates the effective control that
`the Director exerts over APJs.
`
`For each of these reasons, this Court should find
`
`that APJs are inferior officers and reverse the under-
`lying decision on that basis alone.
`
`By providing additional review of patent validity,
`
`IPR and PGR have helped mitigate flaws in the patent
`system. The advent of the inter partes review (IPR)
`and post-grant review (PGR) proceedings has led to
`
`

`

`4
`
`reduced patent litigation rates and reduced patent lit-
`igation costs. While amici argue that severance of civil
`service protections is unnecessary, Congress would not
`have wished to have such an effective program termi-
`nated when it could be saved by a minor change. If this
`Court finds that APJs are principal officers, it should
`bless the curing action taken by the Arthrex court and
`uphold severance of APJs civil service protections.
`--------------------------------- ♦ ---------------------------------
`
`ARGUMENT
`I. THE DIRECTOR ALONE HAS THE ABILITY
`TO FORMULATE POLICY
`
`The America Invents Act (AIA), as codified in 35
`
`U.S.C. § 311 et seq., gave the Director of the USPTO the
`authority to prescribe regulations “establishing and
`governing inter partes review under this chapter.” 35
`U.S.C. § 316(a)(4). The Director has also promulgated
`rules establishing that he and he alone is the final au-
`thority on what decisions of the PTAB will become
`precedential.
`
`In contrast, the authority of an APJ “does not in-
`
`clude any authority to formulate policy for the Govern-
`ment or the Executive Branch, nor does it give
`appellant any administrative duties outside of those
`necessary to operate her office.” Morrison v. Olson, 487
`U.S. 654, 671-72 (1988).
`
`The Director, not any APJ, has complete authority
`
`over how IPR will be conducted, subject only to the
`
`

`

`5
`
`limits imposed in the statutory text, and thus complete
`authority to direct APJs in the conduct of their work.
`See Edmond v. United States, 520 U.S. 651, 663 (1997).
`This policy control alone illustrates that APJs are
`inferior officers whose superior principal officer is the
`Director.
`
`
`
`A. The Director Formulates Policy Via Rule-
`making; APJs Implement That Policy
`
`The Director’s rulemaking authority extends
`
`broadly across those regulations that establish and
`govern inter partes review. 35 U.S.C. § 316(a)(4). In the
`past two years alone, the Director has employed this
`authority to: make changes to the substantive stand-
`ard employed by APJs when interpreting claims, 83
`Fed. Reg. 51340 (Oct. 11, 2018); create new factors not
`found in statute to be evaluated by APJs during the
`institution process, 83 Fed. Reg. 39989 (Aug. 13, 2018);
`re-interpret how 35 U.S.C. § 101 is to be applied by
`Office personnel, including APJs conducting post-grant
`reviews, 84 Fed. Reg. 50 (Jan. 7, 2019); create pilot pro-
`grams making it easier to amend patents during an
`IPR, 84 Fed. Reg. 9497 (Mar. 15, 2019); and discourage
`institution of more than one proceeding on the same
`patent, 84 Fed. Reg. 33925 (July 16, 2019). And as
`described in Section III, infra, no APJ has ignored or
`contradicted those policies.
`
`No individual APJ has authority to formulate pol-
`
`icy via rules and guidance, and all must follow the
`rules and guidance established by the Director. By
`
`

`

`6
`
`setting out the policy that APJs apply, the Director
`effectively directs the fashion in which APJs conduct
`their work. This is quintessentially supervision of an
`inferior officer.
`
`
`
`B. The Director Formulates Policy Via Des-
`ignation of Opinions as Precedential;
`APJs Are Bound to Follow That Prece-
`dent
`
`Beyond the Director’s authority to promulgate
`
`rules and guidance for APJs to obey, the Director also
`retains final authority over all determinations of
`precedent at the PTAB. In fact, “no decision will be
`designated or de-designated as precedential or in-
`formative without the approval of the Director.” USPTO,
`PTAB Standard Operating Procedure 2 (Revision 10),
`https://www.uspto.gov/sites/default/files/documents/
`SOP2%20R10%20FINAL.pdf (“SOP2”).
`
`This requirement ensures that the Director con-
`
`trols both the formal rulemaking apparatus for setting
`policy and the precedential caselaw that controls pol-
`icy and procedure of the Board. By choosing to desig-
`nate as precedential only those decisions that
`implement the Director’s desired policy, the Director
`exercises a second layer of direction and control over
`the work of APJs.
`
`Again, this type of supervision via setting the pol-
`
`icy to be applied is the type of supervision found
`throughout
`the
`federal government, permitting
`
`

`

`7
`
`principal officers to set policy and allowing inferior
`officers to carry out the execution of that policy.
`
`The policy-based control of APJs by the Director,
`
`and the lack of policy control for APJs, is a strong sig-
`nal that APJs are in fact inferior officers. But in addi-
`tion to the policy control the Director exerts over APJs,
`the Director also retains significant ability to directly
`affect the decisions and work of the APJs.
`
`
`II. THE DIRECTOR HAS THE ABILITY TO
`EFFECTIVELY DIRECT AND CONTROL
`ADMINISTRATIVE PATENT JUDGES, REN-
`DERING THEM INFERIOR OFFICERS
`
`Another fundamental distinction that marks an
`
`officer as an inferior officer, rather than a principal
`officer, is that inferior officers are “officers whose work
`is directed and supervised at some level by” a principal
`officer. Edmond v. United States, 520 U.S. 651, 663
`(1997).
`
`The Director of the USPTO is a principal officer.
`
`35 U.S.C. § 3(a)(1). In that role, he exhibits significant
`direction and supervision of the work conducted by the
`APJs of the Board. This direction includes binding
`APJs to policy guidance the Director devises and sin-
`gle-handedly designating opinions as having preceden-
`tial status, determining which IPRs APJs will hear,
`determining if there will be an instituted IPR for an
`APJ to hear, and even rehearing and revising APJ’s
`opinions through a panel convened at the Director’s
`
`

`

`8
`
`sole discretion and composed of the Director and his
`hand-picked subordinates.
`
`These tools, all available to the Director, allow the
`
`Director to completely control the exercise of authority
`by a judge of the Patent Trial and Appeal Board. No
`APJ may issue an effective decision that implements a
`policy contrary to the Director’s desired policy; if one
`tries, they would be subject to reversal at the Director’s
`initiative and, if necessary, to removal from their role.
`All of these practices are hallmarks of the direction
`and supervision of an inferior officer by a principal
`officer.
`
`
`
`A. The Director Bears Sole Authority to
`Set the Policies the APJs Must Follow,
`Directing Their Actions
`As discussed in Section I, supra, the Director bears
`
`sole responsibility for policy-making for the policies
`APJs must implement. 35 U.S.C. § 3(a)(2)(A); 35 U.S.C.
`§ 316(a). And APJs are bound to follow that direction.
`A failure to follow the Director’s policy guidance may
`lead to removal from an IPR, removal from hearing
`any IPRs, or even removal from the Board altogether.
`
`
`
`B. The Director Controls Whether an APJ
`Will Hear Any Particular Case, or Even
`Whether the APJ Will Hear Any Cases
`at All
`
`Beyond general policy-setting authority, the Direc-
`
`tor also is given the sole statutory authority to
`
`

`

`9
`
`designate which APJs will hear each inter partes re-
`view. 35 U.S.C. § 6(c). And while the Director has per-
`mitted the Chief Judge of the PTAB to assign panel
`members in general, the Director explicitly “retains
`his or her own statutory authority to designate pan-
`els.” USPTO, PTAB Standard Operating Procedure 1
`(Revision 15), https://www.uspto.gov/sites/default/files/
`documents/SOP%201%20R15%20FINAL.pdf (“SOP1”).
`In addition to authority to determine which proceed-
`ings an APJ may participate in, the Director is also the
`sole party authorized to determine if a proceeding
`should be instituted at all. 35 U.S.C. § 314(a).
`
`The net result of these twin authorities is that the
`
`Director may determine whether any given APJ will
`hear any cases at all, and determines for any given
`case which APJs will be permitted to hear it. This
`type of control via assignment is a quintessential form
`of supervision, rendering the Director the principal
`officer who is the superior of the inferior officer APJ.
`Edmond, 520 U.S. at 662. It is also strongly analogous
`to the independent counsel of Morrison. Morrison v. Ol-
`son, 487 U.S. 654 (1988).
`
`
`
`1. The independent counsel in Morri-
`son was sufficiently subject to con-
`trol by the Attorney General
`In Morrison, the Attorney General—a principal
`
`officer—could, based on information received, prelimi-
`narily investigate whether there are “reasonable
`grounds to believe that further investigation or
`
`

`

`10
`
`prosecution is warranted.” 28 U.S.C. § 592(b)(1). In the
`event that such grounds exist, the Attorney General,
`in conjunction with the Special Division, would select
`an independent counsel and define the jurisdiction of
`the independent counsel. Morrison, 487 U.S. at 661.
`The independent counsel would then pursue the pro-
`posed investigation, independent of any direct super-
`vision by the Attorney General or Special Division.
`While not directly supervised by the Attorney General,
`the independent counsel was still obliged to follow the
`established policies of the Department of Justice in
`their investigation. 28 U.S.C. § 594(f ). The Attorney
`General could remove the independent counsel, but
`only “for good cause, physical disability, mental inca-
`pacity, or any other condition that substantially im-
`pairs the performance of such independent counsel’s
`duties.” 28 U.S.C. § 596(a)(1).
`
`
`
`2. APJs are subject to analogous, but
`greater, control by the Director
`
`Similarly, the Director of the USPTO receives a
`
`petition for inter partes review. 35 U.S.C. § 312. If the
`Director determines that there is “a reasonable likeli-
`hood that the petitioner would prevail with respect to
`at least 1 of the claims challenged in the petition,” he
`may choose to authorize an inter partes review. 35
`U.S.C. § 314(a). And if the Director chooses to institute
`a proceeding, he selects the APJs who will be assigned
`to that proceeding. 35 U.S.C. § 6(c). The Director is per-
`mitted to remove APJs from any case at any time, for
`any reason. 35 U.S.C. § 6(c); see also SOP1 (“authority
`
`

`

`11
`
`of the Director to designate, de-designate, or otherwise
`alter in any way at any time, panels in his or her sole
`discretion”). APJs are bound to follow the guidance of
`the Director. See Section I, supra. The Director can
`also remove APJs from employment entirely “for such
`cause as will promote the efficiency of the service.” 5
`U.S.C. § 7513(a).
`
`
`
`3. If the independent counsel of Morri-
`son is an inferior officer, then APJs—
`subject to greater control and less in-
`sulated from removal—must also be
`Both the independent counsel of Morrison and
`
`APJs are selected by a principal officer to serve a spe-
`cific purpose within a limited jurisdiction, whether a
`specific investigation of crimes or a specific investiga-
`tion of a patent. Each only receives that grant of au-
`thority if the principal officer issues a preliminary
`decision that the assignment is reasonably likely to
`bear fruit. Both are bound to the general policy set
`forth by their principal officer. And while APJs main-
`tain their membership in the Board when not hearing
`a proceeding, that membership itself comes with no
`specific authority to exercise the authority of the
`United States; their sole authority stems from their
`assignment to specific proceedings by the Director.
`They are, in practice if not in Human Resources files,
`temporary appointees to each proceeding, with their
`offices being created and terminated as they are as-
`signed to and removed from proceedings.
`
`

`

`12
`
`Further, the Director has significantly greater
`
`powers of removal than the Attorney General in Mor-
`rison. The Attorney General could remove the counsel
`only with cause; the Director can remove an APJ from
`a proceeding without any cause whatsoever, and can
`terminate an APJ’s employment entirely based on a
`determination that their conduct harms the efficiency
`of the service. One such cause, as expressed by the dis-
`sent from denial of rehearing en banc, would be “[f ]ail-
`ing or refusing to follow the Director’s policy or legal
`guidance.” Arthrex, Inc. v. Smith & Nephew, Inc., 953
`F.3d 760, 787 (Fed. Cir. 2020) (Hughes, J., dissenting).
`
`Given the significant similarities between APJs
`
`and the independent counsel of Morrison, ranging from
`the way in which they are assigned to proceedings to
`their obligation to abide by the policy guidance of their
`principal officer, the Morrison holding leads to the con-
`clusion that APJs are inferior officers.
`
`
`
`C. The Director Can Unilaterally Deter-
`mine to Rehear an APJ’s Decision, and
`Can Do So Accompanied by Hand-
`Picked Subordinates to Ensure the De-
`sired Outcome
`
`If an APJ were to reach a disfavored outcome not
`
`yet subject to guidance or even to ignore the Director’s
`policy guidance, then the Director retains the ability to
`unilaterally determine that that decision should be re-
`heard and retains the ability to have it reheard by the
`Director’s chosen panel. This process was previously
`
`

`

`13
`
`discussed by this Court in the Oil States argument,
`where Chief Justice Roberts described the situation
`where the Director “can change [the] panels if she
`doesn’t agree with the direction they’re going, that she
`can add new judges to the panel . . . and I think consti-
`tutionally this may be fine, [is] a tool of the executive
`activity.” Transcript of Argument in Oil States v.
`Greene’s Energy at 33:2-8 (Nov. 27, 2017).
`
`SOP2 sets out the process by which the Director
`
`achieves this panel stacking. Per SOP2, the “Director
`may convene a Precedential Opinion Panel to review a
`decision in a case and determine whether to order sua
`sponte rehearing, in his or her sole discretion.” SOP2
`at 5. Having convened such a panel, “Precedential
`Opinion Panel members are selected by the Director.”
`SOP2 at 4. The members of the PTAB include the
`Director, the Deputy Director, the Commissioner for
`Patents, and the Commission for Trademarks, as well
`as more than 200 APJs. 35 U.S.C. § 6(a); USPTO Per-
`formance and Accountability Report, FY2020 (Nov.
`2020). The Deputy Director is nominated by the Direc-
`tor and appointed by the Secretary of Commerce. 35
`U.S.C. § 3(b)(1).
`
`Faced with a decision the Director objects to, it is
`
`within the Director’s power and authority to sua sponte
`convene a Precedential Opinion Panel, removing the
`original APJ from the matter and placing the Director
`himself onto the panel. He may also select the Deputy
`Director, who owes her position to the Director’s selec-
`tion and nomination, as well as the Director’s choice of
`any APJ from among more than 200 APJs. The ability
`
`

`

`14
`
`to select the officials charged with hearing or rehear-
`ing the proceeding is effectively the ability to select
`the outcome, particularly when each of the members of
`the Board is obligated to follow the policy guidance of
`the Director at the potential cost of losing their posi-
`tion.
`
` While one or two APJs might theoretically disa-
`gree with that guidance, the ability to express to a se-
`lected APJ what the Director believes to be the correct
`interpretation of the statute and policy is a strong tool
`to ensure that the selected APJ will abide by the Di-
`rector’s interpretation. In practice, the ability to select
`and stack precedential panels is equivalent to a power
`to directly and individually review a decision.
`
`The ability to panel-stack to achieve the desired
`
`outcome is another mechanism by which the Director
`controls and supervises APJs, further cementing
`their status as inferior officers. Panel-stacking might
`or might not create a due process concern or result
`in a policy that exceeds the Director’s authorized
`role, but such “shenanigans” are properly the subject
`of the Administrative Procedure Act or constitutional
`challenges to particular decisions. Cf. Cuozzo Speed
`Technologies, LLC v. Lee, 136 S. Ct. 2131, 2142
`(2016).
`
`
`
`
`
`
`

`

`15
`
`III. UNIFORM ADHERENCE BY ADMINIS-
`TRATIVE PATENT JUDGES TO THE DI-
`RECTOR’S EXTRASTATUTORY POLICIES
`SIGNALS THE DIRECTOR’S EFFECTIVE
`CONTROL
`
`Concerns regarding these shenanigans are not hy-
`
`pothetical. Several of the policies set by the Director in
`recent years are currently subject to challenge under
`the Administrative Procedure Act as exceeding his
`statutory authority. See Apple et al. v. Iancu, Case No.
`5:20-CV-6128 (N.D. Cal., filed Aug. 31, 2020). And these
`policies have led at least one APJ to file a lengthy dis-
`sent from the way in which his panel applied that pol-
`icy, a rare event at the PTAB. See Cisco Systems, Inc. v.
`Ramot At Tel Aviv University, Ltd., IPR2020-00123, Pa-
`per No. 14 (May 15, 2020) (Crumbley, APJ, dissenting).
`But even in disagreeing with the application of the
`precedent, the APJ did not ignore the Director’s extra-
`statutory policy.
` While amici agree with the challengers in that
`case that the policy in question is not one the Director
`is authorized to create, amici are unaware of, and Ar-
`threx has not identified, any instance in which an APJ
`has ignored policy set by the Director in favor of his or
`her own preferred policy. The uniform adherence of
`more than 200 APJs to the Director’s preferred policy
`is itself evidence of the Director’s de facto control and
`direction of the APJs, made all the more salient when
`at least some of those policies may be without statu-
`tory backing.
`
`

`

`16
`
`IV. INTER PARTES REVIEW HAS SIGNIFI-
`CANTLY IMPROVED THE FUNCTION OF
`THE PATENT SYSTEM AND CONGRESS
`WOULD NOT WISH TO DISTURB THAT
`IMPROVEMENT
`Since the creation of the inter partes review pro-
`
`cess, the amount and cost of patent litigation has fallen
`significantly. From a peak of 6,114 patent lawsuits filed
`in 2013, disputes have fallen to 3,347 in 2019. Unified
`Patents, 2019 Patent Dispute Report—Year in Review,
`Fig. 1 (Jan. 1, 2020), https://www.unifiedpatents.com/
`insights/2019/12/30/q4-2019-patent-dispute-report. And
`the cost of those lawsuits has fallen as well, from a me-
`dian of $5,500,000 for a single patent lawsuit in 2013
`to a median of $4,000,000 in 2019. AIPLA, Report of
`the Economic Survey 2019 at 50 (2019). Much of this
`decline appears attributable to the impacts of IPR.
`Landau, IPR and Alice Appear Responsible for Reduced
`Patent Litigation Costs, Patent Progress (Oct. 18, 2018),
`https://www.patentprogress.org/2018/10/18/ipr-and-
`alice-appear-responsible-for-reduced-patent-litigation-
`costs/.
`Amici’s members have benefited from these posi-
`
`tive changes to the patent system. Rather than devote
`financial and employee resources to legal disputes
`over intellectual property—especially disputes over
`the kind of invalid patents IPR was designed to elimi-
`nate—they have instead been able to devote those re-
`sources to creating new innovation. This is precisely
`what Congress envisioned in creating the inter partes
`
`
`

`

`17
`
`review process—the creation of “quick and cost effec-
`tive alternatives to litigation.” H.R. Rep. No. 112-98, at
`48 (2011).
`
`Further, while this case focuses on the role of APJs
`
`in hearing inter partes reviews, that is not their only
`function. They also hear ex parte appeals from patent
`applications under examination, hear appeals of ex
`parte reexaminations, and conduct interference and
`derivation proceedings to determine which of two ap-
`plicants for the same invention is entitled to a patent
`right. Finding their appointment to be unconstitu-
`tional throws into question those other proceedings as
`well. The work of similar employees in roles across the
`federal government would also be questioned if the
`Board’s APJs were determined to be unconstitution-
`ally appointed principal officers.
` While amici believe no fix is necessary, as the APJs
`are inferior officers operating under the direction, con-
`trol, and supervision of the Director, amici submit that
`the severance of removal protections would have been
`preferred by Congress to striking down the appoint-
`ments of all PTAB judges. In determining whether a
`provision is severable, a court must ask whether “the
`legislature [would] have preferred what is left of its
`statute to no statute at all.” Ayotte v. Planned
`Parenthood of N. New England, 546 U.S. 320, 330
`(2006). The remainder of the statute is presumptively
`severable unless it is evident that its continued en-
`forcement would produce “a scheme sharply different
`
`
`
`

`

`18
`
`from what Congress contemplated.” Murphy v. NCAA,
`138 S. Ct. 1461, 1482 (2018).
`
`Striking down PTAB appointments entirely would
`
`disrupt patent examination, with applicants unable to
`appeal to the Board adverse decisions from examiners.
`It would block the other long-standing reexamination
`process, ex parte reexamination. And it would block
`derivation proceedings, which are used to determine
`ownership of some of the most valuable technologies
`today. S

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket